Clinical Trial Details
| Trial ID: | L2381 |
| Source ID: | NCT01687582 |
| Associated Drug: | Glp-1 Analog |
| Title: | Effect of GLP-1 Analogs on Psoriasis in Type 2 Diabetic Patients |
| Acronym: | |
| Status: | COMPLETED |
| Study Results: | NO |
| Results: | |
| Conditions: | Type 2 Diabetes|Psoriasis |
| Interventions: | DRUG: GLP-1 analog |
| Outcome Measures: | Primary: Improvement of PASI score, 4 to 6 months | Secondary: Evolution of BMI (body mass index), number of patients with weight loss, 4 to 6 months|Evolution of immunological data, cytokines and T cells, 4 to 6 months|Evolution of histopathological data, thickness, dermis infiltrate in skin plaques and in control areas, 4 to 6 months|Evolution of glycaemic control, HbA1c, 4 to 6 months|Evolution of routine laboratory measures, number of participants with biological adverse effects (pancreatitis enzymes), 4 to 6 months|Evolution of BMI, weight, 4 to 6 months |
| Sponsor/Collaborators: | Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain |
| Gender: | ALL |
| Age: | ADULT, OLDER_ADULT |
| Phases: | |
| Enrollment: | 10 |
| Study Type: | INTERVENTIONAL |
| Study Designs: | Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT |
| Start Date: | 2012-01 |
| Completion Date: | 2013-03 |
| Results First Posted: | |
| Last Update Posted: | 2019-03-12 |
| Locations: | Cliniques universitaires Saint-Luc, Brussels, 1200, Belgium |
| URL: | https://clinicaltrials.gov/show/NCT01687582 |
| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress |
|---|